Aceso Life Science Group Limited - Laporan Laba Rugi (TTM)

Aceso Life Science Group Limited
HK ˙ SEHK ˙ KYG4289B1106
HK$ 0.03 ↓ -0.00 (-3.45%)
2025-09-12
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Aceso Life Science Group Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 43 -43 -129 -142 -154 8 170 142 115 161 207 202 198 11 14 17 -27 -71
Change (%) -200.00 200.00 9.69 8.83 -105.19 2,025.00 -16.18 -19.30 40.00 28.57 -2.17 -2.22 -94.44 27.27 21.43 -258.82 162.96
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 146 140 133 134 135 144 153 160 166 168 171 156 141 111 110 110 108 105
Change (%) -4.45 -4.66 0.75 0.75 6.67 6.25 4.25 4.08 1.51 1.48 -8.77 -9.62 -21.28 -0.45 -0.45 -2.27 -2.33
% of Revenue 339.53 -324.42 -103.10 -94.70 -87.66 1,800.00 90.00 111.93 144.35 104.66 82.61 77.04 71.21 1,009.09 789.29 647.06 -398.15 -147.89
Gross Operating Profit -103 -182 -262 -276 -289 -136 17 -17 -51 -8 36 46 57 -100 -96 -93 -134 -176
Change (%) 77.18 43.56 5.15 4.90 -52.94 -112.50 -200.00 200.00 -85.29 -580.00 29.17 22.58 -275.44 -3.50 -3.63 44.62 30.86
% of Revenue -239.53 424.42 203.10 194.70 187.66 -1,700.00 10.00 -11.93 -44.35 -4.66 17.39 22.96 28.79 -909.09 -689.29 -547.06 498.15 247.89
SG&A 213 208 204 188 171 162 153 147 141 134 126 124 123 124 118 113 114 114
Change (%) -2.11 -2.16 -8.09 -8.80 -5.26 -5.56 -3.92 -4.08 -5.32 -5.62 -1.19 -1.20 0.81 -4.44 -4.64 0.44 0.44
% of Revenue 495.35 -484.88 -158.14 -132.51 -111.04 2,025.00 90.00 103.16 122.61 82.92 60.87 61.48 62.12 1,127.27 846.43 664.71 -420.37 -160.56
R&D
Change (%)
% of Revenue
OpEx 619 478 337 232 126 216 306 250 195 246 297 280 263 235 232 228 224 219
Change (%) -22.78 -29.50 -31.31 -45.57 71.43 41.67 -18.14 -22.16 26.15 20.73 -5.72 -6.07 -10.65 -1.49 -1.51 -1.97 -2.01
% of Revenue 1,439.53 -1,111.63 -261.24 -163.60 -81.82 2,700.00 180.00 175.79 169.57 152.80 143.48 138.27 132.83 2,136.36 1,653.57 1,341.18 -827.78 -308.45
Operating Income -576 -521 -466 -373 -280 -208 -136 -108 -80 -85 -90 -78 -65 -224 -218 -211 -250 -290
Change (%) -9.55 -10.56 -19.96 -24.93 -25.71 -34.62 -20.59 -25.93 6.25 5.88 -13.89 -16.13 244.62 -2.90 -2.99 18.72 15.77
% of Revenue -1,339.53 1,211.63 361.24 263.60 181.82 -2,600.00 -80.00 -75.79 -69.57 -52.80 -43.48 -38.27 -32.83 -2,036.36 -1,553.57 -1,241.18 927.78 408.45
Interest Expense
Change (%)
% of Revenue
Net Income -671 -524 -376 -200 -25 -198 -370 -354 -338 -301 -264 -342 -420 -462 -427 -392 -644 -895
Change (%) -21.98 -28.18 -46.68 -87.53 690.00 87.34 -4.32 -4.52 -10.95 -12.29 29.55 22.81 10.00 -7.58 -8.20 64.16 39.08
% of Revenue -1,560.47 1,217.44 291.47 141.70 16.23 -2,468.75 -217.65 -248.42 -293.91 -186.96 -127.54 -168.89 -212.12 -4,200.00 -3,050.00 -2,305.88 2,383.33 1,260.56

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista